INTERNATIONAL PATENT: IMMATICS BIOTECHNOLOGIES GMBH FILES APPLICATION FOR "ADVANCED TREATMENT MODALITIES FOR ANTI-PRAME TCR-ENGINEERED IMMUNE CELLS"

GENEVA, Feb. 17 -- IMMATICS BIOTECHNOLOGIES GMBH (Paul-Ehrlich-StraBe 1572076 Tubingen) filed a patent application (PCT/EP2025/072917) for "ADVANCED TREATMENT MODALITIES FOR ANTI-PRAME TCR-ENGINEERED IMMUNE CELLS" on Aug 08, 2025. With publication no. WO/2026/033136, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MAYER-MOKLER, Andrea (c/o IMMATICS BIOTECHNOLOGIES GMBHPaul-Ehrlich-StraBe 1572076 Tubingen), HILF, Norbert (c/o IMMATICS BIOTECHNOLOGIES GMBHPaul-Ehrlich-StraBe 1572076 Tubingen), MENDRZYK, Regina (c/o IMMATICS...